Form 4: Amgen VP, Finance & CAO, Matthew C. Busch, Reports Stock Transaction
SEC Form 4
Matthew C. Busch, VP, Finance & CAO of Amgen Inc., reports a transaction involving common stock on May 5, 2024.
Summary
- On May 5, 2024, Matthew C. Busch, VP, Finance & CAO of Amgen Inc., engaged in a transaction involving the company's common stock.
- The transaction involved the disposal of 27 shares at a price of $311.29.
- Following the transaction, Busch directly owns 4,599 shares of Amgen common stock.
- These shares include Restricted Stock Units (RSUs) with various vesting schedules and Dividend Equivalents (DEs).
Sentiment
Score: 5
Explanation: This is a routine regulatory filing, so the sentiment is neutral.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their transactions in the company's stock.
Stakeholder Impact
- The transaction provides transparency to shareholders regarding insider trading activity.
Key Dates
| Date | Description |
|---|---|
| 05/05/2024 | Date of the stock transaction. |
| 04/30/2025 | Vesting date for 43 RSUs. |
| 11/05/2024 | Vesting date for 494 RSUs. |
| 11/05/2025 | Vesting date for 509 RSUs. |
| 05/02/2025 | Vesting date for 71 RSUs. |
| 05/02/2026 | Vesting date for 73 RSUs. |
| 05/02/2025 | Vesting date for 97 RSUs. |
| 05/02/2026 | Vesting date for 98 RSUs. |
| 05/02/2027 | Vesting date for 101 RSUs. |
| 05/07/2024 | Date of signature. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.